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Abstract
Background: Walking and cardiovascular mortality are inversely associated in type 2 diabetes, but few studies have
objectively measured associations of walking with individual cardiovascular risk factors. Such information would be useful
for ‘‘dosing’’ daily steps in clinical practice. This study aimed to quantify decrements in blood pressure and glycated
hemoglobin (A1C) per 1,000 daily step increments.
Methodology/Principal Findings: Two hundred and one subjects with type 2 diabetes underwent assessments of step
counts (pedometer-measured), blood pressure, A1C and anthropometric parameters. Due to missing data, the final analysis
was conducted on 83 women and 102 men, with a mean age of 60 years. Associations of daily steps with blood pressure
and A1C were evaluated using sex-specific multivariate linear regression models (adjusted for age, ethnicity, and BMI).
Potential sex differences were confirmed in a combined model (women and men) with interaction terms. Mean values for
daily steps, blood pressure, A1C and BMI were 5,357 steps/day; 137/80 mm Hg; 7.7% and 30.4 kg/m
2 respectively. A 1,000
daily step increment among women was associated with a 22.6 (95% CI: 24.1 to 21.1) mm Hg change in systolic and a
21.4 (95% CI: 22.2 to 20.6) mm Hg change in diastolic blood pressure. Among men, corresponding changes were 20.7
(95% CI: 22.1 to 0.7) and 20.6 (95% CI: 21.4 to 0.3) mm Hg, respectively. Sex differences were confirmed in combined
models. Step counts and A1C did not demonstrate clinically important associations.
Conclusions/Significance: A 1,000 steps/day increment is associated with important blood pressure decrements among
women with type 2 diabetes but the data were inconclusive among men. Targeted ‘‘dose increments’’ of 1,000 steps/day in
women may lead to measurable blood pressure reductions. This information may be of potential use in the titration or
‘‘dosing’’ of daily steps. No associations were found between step count increments and A1C.
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Introduction
Physical activity is associated with lower rates of all-cause
mortality in the general population [1]. However, physical activity
promotion is an underutilized therapeutic strategy in patients with
cardio-metabolic disease. Walking is a cheap, easily accessible
means of increasing physical activity, and studies indicate that it is
the preferred form of activity among overweight adults with type 2
diabetes [2]. In the Nurses’ Health Study, among over 5,000
women with diabetes, those in the highest quartile for self-reported
walking were 34% less likely to have died up to 8 years later [3]. In
the all-male Health Professionals’ Follow-up Study, among over
3,000 men with diabetes diagnosed after 30 years of age, men in
the highest walking quintile were 43% less likely to have died up to
14 years later [4]. Similarly, the National Health Interview Survey
(n=2,896) demonstrated that walking more than two hours per
week was associated with a more than 34% reduction in both all-
cause and vascular disease mortality up to 9 years later among
men and women with diabetes [5].
In healthy adults aged 26–80 years, lower levels of pedometer or
accelerometer-based categories of physical activity have been
shown to be associated with a higher odds or prevalence of adverse
cardio-metabolic risk factors [6,7]. In addition, a previous
systematic review and meta-analysis determined that pedometer-
based programs may lead to higher daily step counts and lower
blood pressure levels in several clinical populations, particularly
when a specific target is provided (e.g., 10,000 steps/day) [8].
Although this supports the potential utility of ‘‘walking prescrip-
tions’’, ‘‘dose-response curves’’ have not been defined in the
literature. Moreover, there is a lack of studies assessing the
association of daily step counts with individual cardiovascular risk
factors, particularly in a treated clinical cohort: the existing studies
are small, with inconsistent results and different measures of
walking [9–12]. Therefore, the present study aims to contribute to
the evidence base for what constitutes an important ‘‘daily step
increment’’.
Well-designed observational studies evaluating the associations
of objectively measured walking with individual cardiovascular risk
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walking is of measurable benefit in an already-treated population
with type 2 diabetes. By providing estimates of step-related
improvements in individual cardiovascular risk factors, this
information can be used to facilitate the development of ‘‘walking
prescriptions’’. The availability of step counters or pedometers for
real-time measurement of walking makes this strategy both
practical and economically feasible. A widely used classification
scheme for daily step counts initially proposed by Tudor-Locke
and Bassett [13] and subsequently revised [14] categorizes
individuals achieving ,5,000 steps/day as sedentary; 5,000–
7,499 as low active; 7,500–9,999 as somewhat active; 10,000–
12,499 as active; and $12,500 as highly active [13–15]. This study
proposes to build on the existing body of evidence related to
pedometer-measured physical activity through measurement of
the association of daily steps with specific vascular risk factors.
Blood pressure and glycated hemoglobin (abbreviated A1C, a
marker the degree of glycemic control over the preceding 3
months) are established vascular risk factors and important
therapeutic targets for reducing cardiovascular mortality, stroke
and micro-vascular complications in patients with type 2 diabetes
[16].
Specifically, the present study aims to quantify the changes in
systolic blood pressure, diastolic blood pressure, and A1C
associated with each 1,000 daily step increment among women
and men with type 2 diabetes. At a moderate walking pace, 1,000
steps per day may be achieved in approximately ten minutes; thus
a 1,000 steps/day increment arguably represents a feasible ‘‘dose
increase in daily steps,’’ keeping an eye to eventual clinical
application [17]. We performed sex-specific analyses given that
previous studies have suggested that women reduce their blood
pressure somewhat more consistently with exercise training than
men [18–20].
Methods
Data for the present study were derived from a cohort study
designed to assess for seasonal differences in step counts and A1C.
Data collection procedures for our cohort have been detailed
previously but are summarized here [21]. Participants presented
for quarterly assessments over one year (once per season)
performed by research personnel at the Division of Internal
Medicine, Montreal General Hospital site of the McGill University
Health Centre. The main analyses reported here are based on data
collected during and immediately after the first study centre visit.
These are cross-sectional data as the goal was to capture
associations across a wide range of daily step counts and
cardiovascular risk factor levels occurring across individuals rather
than within individuals. In a secondary analysis, we also examined
within-individual associations using the available longitudinal data.
Participants
Two hundred and one adults followed for type 2 diabetes were
recruited through McGill University affiliated outpatient clinics
between June 2006 and June 2008 (Montreal, Canada). To ensure
the accuracy of the pedometer measurements, participants were
required to have a normal gait and a BMI #40 kg/m
2 [22,23].
Patients with stable chronic conditions were permitted to enroll.
Women who were pregnant or planning pregnancy were
excluded.
Procedures
Demographic information (sex, date of birth, ethnicity and level
of education) and a detailed medical history (including duration of
diabetes and current medication use) were obtained via question-
naire and interview at each study centre visit. Data were collected
on cardiovascular risk factors, physical activity including daily
steps, anthropometric parameters and dietary information, as
outlined below. All assessments were performed at our study
centre at the McGill University Health Centre (Division of
Internal Medicine). For the purpose of our analyses, ‘smokers’
included persons who quit smoking less than a year prior to entry
into the study.
Cardiovascular Risk Factors
Blood pressure measurements were taken in the left arm using
an appropriate-sized cuff (Omron HEM 747 IC blood pressure
monitor) after a 15 minute rest period. A1C was measured from
blood samples collected at each visit using high-pressure liquid
chromatography.
Daily Step and Physical Activity Measurement
Daily step counts were measured using Yamax SW-200
pedometers. The accuracy and reliability of this device has been
previously demonstrated [24]. At each of the four visits,
participants were provided with three pedometers, labeled A, B
and C. All pedometers were fitted with a snap-on plastic cover that
concealed the viewing window which was sealed using an acetate
security seal (Novovision). This seal was placed along the margin of
the pedometer and the cover so that any attempt to tamper with
the seal was therefore evident. Participants were instructed to wear
pedometer A during waking hours for 7 consecutive days, after
which it was removed and replaced by pedometer B for another 7
consecutive days. Pedometers A, B and C were then mailed to our
study centre in a pre-paid, pre-addressed, padded courier
envelope. Pedometer C served to measure (false) steps registered
during the mailing process (‘‘postman steps’’). These postman steps
were subtracted from the step count of each of Pedometers A and
B and the sum of the remaining steps were averaged over the total
time period worn (i.e., 14 days). The Short Last 7 Days Self-
Administered format of the International Physical Activity
Questionnaire (IPAQ) was used to assess self-reported levels of
overall physical activity and to calculate metabolic equivalents per
week [25].
Anthropometric Measurements and Dietary Intake
Weight and height were assessed to the nearest tenth of a
kilogram (SECA 882 electronic scale) and tenth of a centimeter
(SECA 214 stadiometer) respectively, with the subject wearing
light clothing and with shoes removed. Waist circumference was
measured midway between the iliac crest and the lower rib
margin. Hip circumference was measured at the point of greatest
posterior extension of the buttocks. The waist-to-hip ratio was
calculated by dividing the waist circumference by the hip
circumference. BMI was calculated by dividing the weight in
kilograms by the square of the height in meters. The Quebec Food
Frequency Questionnaire (FFQ), previously validated in a sample
of adults in the Montreal region, was used to gather dietary
information [26].
Ethics. Procedures were approved by the Institutional
Review Boards (IRB) of McGill University and participating
institutions (McGill University Health Centre, Sir Mortimer Davis
Jewish General Hospital, and Centre de Sante ´ et de Services
Sociaux de la Montagne). All study participants provided written
informed consent prior to the clinical assessments.
Statistical methods. Participants were classified by daily
step quartiles based on their first visit data (Table 1).
Characteristics were computed by daily step quartile as
Steps, Blood Pressure, and Sex
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variables; proportions for categorical variables).
Multivariate linear regression was applied to these data to
evaluate the associations of daily steps with systolic and diastolic
blood pressure and A1C in separate models with adjustment for
potential confounders. Each model was constructed separately for
women and men. Models combining data from women and men
were also examined, with an interaction term between sex and
daily steps, to verify sex differences suggested by sex-specific
models. Residual plots of the most representative models were
examined to verify that the assumptions of linear regression were
met. We examined potential confounders by comparing the beta-
coefficients of the determinant variable of interest across models
containing various combinations of potential confounding vari-
ables. Covariates having the strongest impact on this beta-
coefficient were identified as statistically important confounders
and retained in the final model. These analyses were conducted
using the R statistical package, version 2.8.0 (R Foundation for
Statistical Computing, Vienna, Austria).
Although our primary analysis was based on study participants’
first visit data, each participant had up to four data points over the
course of the year. We used a two-level hierarchical modeling on
these data to examine within-individual associations of blood
pressure (systolic and diastolic) and A1C with daily steps. The first
level of this model included linear regression models of each
outcome within each subject over time. At the second level of these
models, the slopes from the first models were regressed against
potential predictors. Previous analyses of our data demonstrated
that habitual walking patterns differ by season [27]. In keeping
with these findings, we tested season (fall-winter versus spring-
summer) as a potential confounder in our hierarchical modeling.
Hierarchical modeling was performed using winBUGS [28].
Sample Size. It was determined that a sample size of 160
would allow us to examine up to 8 variables in a given model with
reasonable accuracy [29]. In a previous study, adherence for
subjects required to wear a pedometer for 12 consecutive weeks
was 72% [30]. Since our protocol required 2 week periods, we
estimated that our shorter period of monitoring would lend itself to
a higher adherence rate and anticipated an 80% adherence rate. A
final sample size was selected to accommodate for up to 20%
missing information. It was therefore anticipated that with
recruitment of 200 individuals (100 men and 100 women) we
would retain at least 160 individuals.
Results
Two hundred and one individuals (106 men, 95 women)
completed a first assessment. Thirteen participants were excluded
because of missing A1C, blood pressure readings or pedometer
data. The analyses presented were conducted on 188 participants
(86 women, 102 men) for whom the data were complete. First visit
assessments were conducted throughout the year (30% in fall, 20%
in winter, 25% in spring and 25% in summer). Women comprised
46% of the cohort. The mean age of the population was 60.3
years, their average duration of diabetes was 9.6 years, and 68% of
the cohort was Caucasian. Approximately 23% had stable
cardiovascular disease with a four-fold higher prevalence among
the men compared with the women (30% versus 8%). Participants
were obese (mean BMI of 30.3 kg/m
2) and applying the
classification scheme developed by Tudor-Locke and Bassett,
Table 1. Participant Characteristics (n=188) By Daily Step Quartiles.
Step-Count Quartiles
Characteristic #3,512 3,513–5,357 5,358–7,399 $7,400
Women, No. (%) 22 (46) 25 (53) 21 (45) 18 (38)
Age, mean (SD), y 65 (11) 63 (9) 57 (10) 57 (9)
Diabetes duration, mean (SD), y 11 (8) 10 (8) 9 (8) 9 (8)
White, No. (%) 37 (78) 33 (70) 28 (60) 30 (64)
Completed High School, No. (%) 39 (83) 42 (89) 42 (89) 39 (83)
Cardiovascular Disease, No. (%) 12 (26)
* 8 (17)
* 7( 1 5 )
* 7 (15)
*
Current tobacco use, No. (%) 3 (6)
{ 6 (13) 4 (9)
{ 5 (11)
{
Insulin use, No. (%) 21 (45) 16 (34) 12 (26) 14 (30)
$2 Anti-hypertensives, No. (%) 35 (74) 27 (57) 25 (53) 9 (19)
No Anti-hypertensives, No. (%) 6 (13) 5 (11) 10 (21) 17 (36)
Anthropometric Parameters
Waist Circumference, mean (SD), cm 107.2 (12.1) 103.6 (12.1) 100.5 (14.8) 97.1 (12.5)
Hip Circumference, mean (SD), cm 112.8 (10.7) 112.2 (11.8) 110.9 (12.6) 105.0 (10.9)
Waist-to-Hip Ratio, mean (SD) 0.95 (0.07) 0.92 (0.07) 0.90 (0.07) 0.92 (0.09)
Body Mass Index, mean (SD), kg/m
2 31.3 (5.1) 31.7 (5.0) 30.1 (6.7) 28.6 (5.4)
Cardiovascular Risk Factors
Glycated Hemoglobin A1C, mean (SD), % 8.0 (1.9) 7.4 (0.8) 7.6 (1.2) 7.4 (1.3)
Systolic Blood Pressure, mean (SD), mmHg 144 (20) 138 (15) 136 (17) 131 (15)
Diastolic Blood Pressure, mean (SD), mmHg 82 (11) 80 (11) 80 (10) 79 (10)
*Data for 2 subjects missing;
{Data for 1 subject missing;
{Data for 4 subjects missing.
doi:10.1371/journal.pone.0014086.t001
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‘somewhat active’, 4% were ‘active’ and no study participant
was ‘highly active’ [13–15]. The average A1C and systolic blood
pressure were above the 2008 Canadian Diabetes Association
(CDA) recommended targets.
The mean systolic blood pressure, diastolic blood pressure and
A1C were highest among participants in the lowest quartile of
daily steps, and lowest in the highest quartile of daily steps (Table 1;
Figure 1A and 1B). Systolic blood pressure was lowest in the first
daily step quartile and highest in the fourth daily step quartile
(Table 1). More individuals in the lower daily step quartiles
reported use of anti-hypertensive medication use. The largest
decrement in A1C was noted between the first and second quartile
of daily step counts in both women and men. Diastolic blood
pressure and A1C values were more similar from the second
through the fourth daily step quartiles.
Model comparisons suggested that age and ethnicity were
important confounders across all models tested. Additionally, BMI
was a confounder of the association of daily steps with blood
pressure and waist-to-hip ratio was a confounder of the association
of daily steps with A1C. After adjustment for these confounders,
sex-specific analyses (Table 2) indicated that each 1,000 daily step
increment was associated with a 22.6 (95% CI: 24.1, 21.1) mm
Hg change in systolic and a 21.4 (95% CI: 22.2, 20.6) mm Hg
change in diastolic blood pressure among the women. Data
regarding these associations among men, though suggestive of an
inverse association, were inconclusive. In fully adjusted models,
there did not appear to be a clinically important association of
walking with A1C in either women or men (Table 2). In
multivariate models including data from both women and men,
the beta-coefficient for the ‘‘sex*daily steps’’ interaction term
suggested an important sex difference (2.3 (95% CI: 0.4 to 4.1)) for
systolic but not diastolic blood pressure (0.8 (95% CI: 20.2 to
1.9)).
Hierarchical modeling of the longitudinal data demonstrated a
clinically important within-individual inverse association of daily
steps with systolic blood pressure among women, specifically
during the fall-winter period;: a 1,000 daily step increment was
associated with a (21.4mm Hg (95% CI: 22.3, 20.4)) change in
systolic blood pressure (Table 3). The data were inconclusive
among the men. There was no significant within-individual
association between daily steps and A1C. Although season was
an important confounder in these longitudinal analyses, it was not
found to be a confounder in our primary cross-sectional analyses.
Discussion
Our analyses suggest that habitual walking decreases blood
pressure among persons with type 2 diabetes. A 1,000 daily step
increment was associated with as much as a 2.5 mm Hg lower
systolic and a 1.4 mm Hg lower diastolic blood pressure among
women treated for type 2 diabetes. In a longitudinal ‘‘within-
individual’’ analysis, a 1,000 daily step increment was associated
with a 1.4 mm Hg lower systolic blood pressure among women (in
the fall and winter months). Daily steps were not as strongly
Figure 1. Mean systolic blood pressure (A), diastolic blood pressure (B), and A1C (C) by daily step quartile in women and men
treated for type 2 diabetes.
doi:10.1371/journal.pone.0014086.g001
Table 2. Change in Blood Pressure and A1C per 1,000 Daily
Step Increment among Women and Men.
Mean Change (95% CI)
Characteristic Women Men
Systolic blood pressure
*,m mH g 22.6 (24.1 to 21.1) 20.7 (22.1 to 0.7)
Diastolic blood pressure
*,m mH g 21.4 (22.2 to 20.6) 20.6 (21.4 to 0.3)
HbA1c
{,% 20.05 (20.2 to 0.1) 20.1 (20.2 to 0.0)
*Models adjusted for age, ethnicity and BMI;
{Models adjusted for age, ethnicity and waist-to-hip ratio.
doi:10.1371/journal.pone.0014086.t002
Table 3. Hierarchical Modeling of Longitudinal Data,
Demonstrating Seasonal Changes in Blood Pressure per 1,000




Systolic blood pressure, mm Hg 21.4 (22.3 to 20.4) 0.6 (20.3 to 0.15)
Diastolic blood pressure, mm Hg 0.0 (20.5 to 0.6) 0.5 (20.04 to 1.1)
Men
Systolic blood pressure, mm Hg 20.3 (21.1 to 0.4) 0.2 (20.6 to 1.0)
Diastolic blood pressure, mm Hg 20.3 (20.8 to 0.2) 0.2 (20.3 to 0.7)
All hierarchical models adjusted for age, ethnicity and BMI.
doi:10.1371/journal.pone.0014086.t003
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did not demonstrate a clinically important association between
daily steps and A1C in either women or men treated for type 2
diabetes. Clearly, further study is required to confirm these
preliminary findings and to verify thresholds of benefit. Nonethe-
less, our findings indicate that daily step dose increments of 1,000
steps/day could lead to clinically important blood pressure
decrements in women with type 2 diabetes.
Pedometer-based intervention trials in type 2 diabetes have
achieved increases in daily step counts [31,32]. The First Step
program was the largest and longest such trial in diabetes patients
(24weeks;n=42)and demonstratedincreasesof3,370stepsperday
in the intervention armcompared to a 657 daily step decrease in the
controlarmat 16weeks. Therewas anassociated 22.5 mmHg(SD
13.9) change in systolic blood pressure in the intervention arm but a
0.7 mm Hg (SD 13.1) change in the control group. Although the
sample size was insufficient to demonstrate a statistically significant
difference between the two arms, this study supports the potential
effectiveness of pedometer interventions [31]. Our findings suggest
that these interventions might be of greatest benefit in controlling
cardiac risk factors among women. Across a variety of clinical
populations, pedometer-based interventions have been associated
with increases of 2,000 to 3,000 steps per day [8]. Applied to our
data, these interventions might be associated with reductions in
systolic and diastolic blood pressure of 5 to 7.5 mm Hg and 2.8 to
7.2 mm Hg respectively, among women with type 2 diabetes. Blood
pressure reductions of this magnitude are clinically important and
have been shown to be associated with significant reductions in
diabetes-related outcomes such as myocardial infarction and micro-
vascular complications [33].
The stronger association of physical activity with blood pressure
amongthe women inthisstudyisconsistent withotherdatashowing
greater physical activity-associated reductions in blood pressure
among women compared with men [18,19]. These sex differences
raise the possibility that walking might be a more effective modifier
of cardiovascular risk among the women in our cohort and may
have contributed to their lower prevalence of cardiovascular disease
despite theirhigherobesity prevalence(Table1).Alternatively,since
men have a fourfold greater prevalence of heart disease, their
individual cardiovascular risk factors might be more established or
more aggressively controlled with medications and therefore less
modifiable by walking. Further study examining these sex-
differences and exploring possible explanations could offer useful
insights into the mechanisms responsible for the disparity in
cardiovascular risk between women and men.
Our analyses also demonstrated a stronger association between
blood pressure and daily steps in the fall and winter compared with
the spring and summer in women with type 2 diabetes, in the
within-individual analyses. On average, the blood pressure was
higher and exercise levels lower in the fall-winter seasons than the
spring-summer months. This observed seasonal difference may
therefore be reflecting a greater sensitivity of higher blood
pressures to daily steps, or a threshold effect, such that an increase
in daily step counts may have greater benefits at the lower levels of
activity in the fall and winter months.
Our findings support the need for a large pedometer-based
intervention trial that examines the impact of 1,000 daily step
increments on blood pressure in type 2 diabetes. Furthermore,
since our study population is restricted to patients with diabetes
being treated at tertiary care facilities, future studies in a less
selected population may have greater generalisability. While our
findings indicate a stronger association of step counts and blood
pressure in women with type 2 diabetes, a larger study may have
confirmed an association in men, albeit likely with a ‘‘dose’’
greater than 1,000 steps/day. We acknowledge that step counts
may include not only walking but all step-related physical activity
such as dancing or stair-climbing, although walking is the most
frequent type of physical activity reported by diabetes patients.
Our study is limited by its cross-sectional nature, and as such the
associations described cannot be assumed to be causal. Further-
more, we acknowledge the potential for walking pace and the
intensity of walking to impact the cardiovascular risk factors
evaluated. Randomized control studies employing strategies to
account for the pace of walking are needed to confirm these
associations and to define dose-response thresholds of benefit in
populations for which its use is intended. Community-based
studies should also be performed to validate the efficacy of
pedometer-based ‘‘walking prescriptions’’.
Despite these limitations, we believe that our findings are a
critical first step in establishing dose-response curves for step
counts with blood pressure in patients treated for diabetes and
could facilitate the development of individual exercise prescrip-
tions that provide patients with more tangible goals for physical
activity. Given the economic feasibility and acceptability of
walking in sedentary populations, a prescription of daily steps
may prove to be an effective and accepted therapeutic intervention
for improving control of cardiovascular risk factors such as blood
pressure.
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